The U.S. orthopedic imaging modalities and U.S. orthopedic surgical navigation systems market is segmented into U.S. orthopedic imaging modalities market and U.S. orthopedic surgical navigation systems market. The report highlights that the U.S. orthopedic imaging modalities market was valued at $2,697.8 million in 2022 and is expected to reach $3,989.9 million by the end of 2031. The market is expected to grow at a CAGR of 4.44% during the forecast period 2022-2031. The market is driven by factors such as technological advancements in the imaging field, the increasing incidences of orthopedic diseases and bone injuries, and the growing demand for point of care (POC) ultrasound systems in orthopedic applications. In addition to this, the report also highlights that the U.S. orthopedic surgical navigation systems market was valued at $262.9 million in 2022 and is expected to reach $460.9 million by the end of 2031. The market is expected to grow at a CAGR of 6.43% during the forecast period 2022-2031. The market is driven by factors such as the increasing number of joint replacement surgery and the increasing preference for minimally invasive surgery.

Market Lifecycle Stage

The U.S. orthopedic imaging modalities market is in the developed phase. The rising incidence of orthopedic indications and the upsurge in technological advancements are some of the major opportunities in the U.S. orthopedic imaging modalities market. Furthermore, some of the current key trends in the market are the inclination toward magnetic resonance imaging (MRI) systems and the integration of artificial intelligence (AI) in imaging modalities.

On the other hand, the U.S. orthopedic surgical navigation systems market is in the developing phase. The increasing preference for minimally invasive surgeries (MIS) and rising numbers of joint replacement surgeries are some of the major opportunities in the U.S. orthopedic surgical navigation systems market.

Impact of COVID-19

The COVID-19 pandemic has impacted practically all sectors and social functions worldwide, including the U.S. orthopedic imaging modalities and U.S. orthopedic surgical navigation systems market. The COVID-19 pandemic led to a decline in the U.S. orthopedic imaging modalities and U.S. orthopedic surgical navigation systems devices market, as screening, elective, and surgical procedures were stopped during the lockdown.

Overall, the supply side was negatively impacted, especially during the peak of the COVID-19 pandemic. The significantly high number of screening, elective, and surgical procedures resumed after the restrictions were lifted, which offset the negative impact and led to the growth of the market in 2021.

In addition to this, the COVID-19 pandemic also helped in the adoption of disposable access devices and hand instruments. Single-use devices eliminate the risk of cross-contamination, which turned out to be a favorable condition for their adoption during the COVID-19 pandemic.

Market Segmentation:

U.S. Orthopedic Imaging Modalities Market

Segmentation 1: by Application

• Hip
• Knee
• Spine
• Other Extremities

The U.S. orthopedic imaging modalities devices market (by application) is expected to be dominated by the spine segment.

Segmentation 2: by Modality

• X-Ray
• Computed Tomography (CT) Scanners
• Magnetic Resonance Imaging (MRI) Systems
• Ultrasound Systems

The U.S. orthopedic imaging modalities devices market (by modality) is expected to be dominated by the X-Ray segment.

Segmentation 3: by End User

• Hospitals
• Ambulatory Surgery Centers
• Others

The U.S. orthopedic imaging modalities devices market (by end user) is dominated by the hospitals segment.

U.S. Orthopedic Surgical Navigation Systems Market

Segmentation 1: by Application

• Joints
• Spine

The U.S. orthopedic surgical navigation systems market (by application) is expected to be dominated by the spine segment.

Recent Developments in the U.S. Orthopedic Imaging Modalities and U.S. Orthopedic Surgical Navigation Systems Market

Demand – Drivers and Limitations

U.S. Orthopedic Imaging Modalities Market

The following are the drivers for the U.S. orthopedic imaging modalities market:

• Technological Advancements in Imaging
• Increasing Incidences of Orthopedic Diseases and Bone Injuries
• Growing Demand for POC Ultrasound Systems in Orthopedic

The market is expected to face some limitations as well due to the following challenges:

• Health Risks and Healthcare Costs from Potentially Inappropriate High-Cost Imaging
• Recall of Imaging Systems

U.S. Orthopedic Surgical Navigation Systems Market

The following are the drivers for the U.S. orthopedic surgical navigation systems market:

• Increasing Number of Joint Replacement Surgeries
• Increasing Preference for Minimally Invasive Procedures

The market is expected to face some limitations as well due to the following challenges:

• High Cost of Robotic Navigation System

How can this report add value to an organization?

U.S. Orthopedic Imaging Modalities Market

Application: The application segment helps readers understand the various applications of U.S. orthopedic imaging modalities in the market.

Modality: The modality segment helps the readers understand the different types of modalities available and their significance in the U.S. orthopedic imaging modalities market. Moreover, the study provides the readers with a detailed understanding of the four main segments, namely, X-Ray, computed tomography (CT) scanners, magnetic resonance imaging (MRI) systems, and ultrasound systems.

U.S. Orthopedic Surgical Navigation Systems Market

Application: The application segment helps readers understand the various applications of U.S. orthopedic surgical navigation systems in the market.

U.S. Orthopedic Imaging Modalities and U.S. Orthopedic Surgical Navigation Systems Market

Growth/Marketing Strategy: The U.S. orthopedic imaging modalities and U.S. orthopedic surgical navigation systems market has witnessed major development by key players operating in the market, such as product launches, business expansions, partnerships, collaborations, and regulatory and legal approvals. The most favored strategy for the companies has been regulatory and legal activities and new offerings to strengthen their position in the market. For instance, in February 2022, FUJIFILM Holdings Corporation launched the Sonosite LX ultrasound system, and in August 2021, DePuy Synthes, a subsidiary of Johnson & Johnson, received FDA clearance for VELYS robotic-assisted solution.

Competitive Strategy: The key players in the U.S. orthopedic imaging modalities and U.S. orthopedic surgical navigation systems market analyzed and profiled in the study involve established and emerging players that offer different products for visualization of the joints and spine for diagnostic as well as therapeutic purposes. Moreover, a detailed competitive benchmarking of the players operating in the U.S. orthopedic imaging modalities and U.S. orthopedic surgical navigation systems market has been done to help the reader understand the ways in which players stack against each other, presenting a clear market landscape. Moreover, comprehensive competitive strategies such as partnerships, agreements, collaborations, mergers, and acquisitions will help the reader understand the untapped revenue pockets in the market.

Key Market Players and Competition Synopsis

Profiled companies have been selected based on inputs gathered from primary experts and analyzing company coverage, product portfolio, and market penetration.

Key Companies Profiled

• Canon Inc.
• FUJIFILM Holdings Corporation
• General Electric Company
• Johnson & Johnson
• Konica Minolta, Inc.
• Koninklijke Philips N.V.
• Medtronic plc
• OrthAlign, Inc.
• Shimadzu Corporation
• Siemens Healthineers AG
• Smith & Nephew plc
• SonoScape Medical Corp.
• Stryker Corporation
• United Imaging Healthcare Co., Ltd.
• Zimmer Biomet Holdings, Inc.

Table of Contents

1 Market
1.1 Market Outlook
1.1.1 Product Definition
1.1.2 Inclusion and Exclusion Criteria
1.1.3 Key Findings
1.1.4 Assumptions and Limitations
1.1.5 Market Scenario
1.1.5.1 U.S. Orthopedic Imaging Modalities Market
1.1.5.1.1 Realistic Growth Scenario
1.1.5.1.2 Optimistic Growth Scenario
1.1.5.1.3 Pessimistic Growth Scenario
1.1.5.2 U.S. Orthopedic Surgical Navigation Systems Market
1.1.5.2.1 Realistic Growth Scenario
1.1.5.2.2 Optimistic Growth Scenario
1.1.5.2.3 Pessimistic Growth Scenario
1.2 Industry Outlook
1.2.1 Patent Analysis
1.2.1.1 U.S. Orthopedic Imaging Modalities Market
1.2.1.1.1 Patent Analysis (by Year)
1.2.1.1.2 Awaited Technological Developments
1.2.1.2 U.S. Orthopedic Surgical Navigation Systems Market
1.2.1.2.1 Patent Analysis (by Year)
1.2.1.2.2 Awaited Technological Developments
1.2.2 Regulatory Landscape
1.2.3 Product Benchmarking
1.3 Impact of COVID-19 on the U.S. Orthopedic Imaging Modalities and Surgical Navigation Systems Market
1.3.1 Impact on Facilities
1.3.2 Impact on Modalities Adoption
1.3.3 Impact on Market Size
1.3.3.1 Pre-COVID-19 Phase
1.3.3.2 During-COVID-19 Phase
1.3.3.3 Post-COVID-19 Phase
1.4 Business Dynamics
1.4.1 U.S. Orthopedic Imaging Modalities Market
1.4.1.1 Impact Analysis
1.4.1.2 Business Drivers
1.4.1.2.1 Technological Advancement in Imaging
1.4.1.2.2 Increasing Incidences of Orthopedic Diseases and Bone Injuries
1.4.1.2.3 Growing Demand for Point-of-Care Ultrasound Systems (POCUS) in Orthopedics
1.4.1.3 Business Restraints
1.4.1.3.1 Health Risks and Healthcare Costs Arising from Potentially Inappropriate High-Cost Imaging
1.4.1.3.2 Recall of Imaging Systems
1.4.1.4 Business Opportunities
1.4.1.4.1 Leveraging Partnerships to Expand Business Opportunities
1.4.1.4.2 Increase in Usage of Dual Modality Imaging or Hybrid Imaging
1.4.1.5 Business Trends
1.4.2 U.S. Orthopedic Surgical Navigation Systems Market
1.4.2.1 Impact Analysis
1.4.2.2 Business Drivers
1.4.2.2.1 Increasing Number of Joint Replacement Surgeries
1.4.2.2.2 Increasing Preference for Minimally Invasive Procedures
1.4.2.3 Business Restraints
1.4.2.3.1 High Cost of Robotic Orthopedic Surgical Navigation System
1.4.2.4 Business Opportunities
1.4.2.4.1 Leveraging Synergies to Diversify Business Portfolio
2 U.S. Orthopedic Imaging Modalities Market (by Application)
2.1 Overview
2.2 Growth-Share Matrix
2.3 Hip
2.4 Knee
2.5 Spine
2.6 Other Extremities
3 U.S. Orthopedic Imaging Modalities Market (by Modality)
3.1 Overview
3.2 Growth-Share Matrix
3.3 X-Ray
3.3.1 Market Dynamics
3.3.2 Procedure Volume
3.3.2.1 U.S. Orthopedic Imaging Modalities Market (by Application)
3.3.2.2 U.S. Orthopedic Imaging Modalities Market (by State)
3.3.3 Market Size and Forecast
3.3.3.1 U.S. Orthopedic Imaging Modalities Market (by Application)
3.4 Computed Tomography (CT) Scanners
3.4.1 Market Dynamics
3.4.2 Procedure Volume
3.4.2.1 U.S. Orthopedic Imaging Modalities Market (by Application)
3.4.2.2 U.S. Orthopedic Imaging Modalities Market (by State)
3.4.3 Market Size and Forecast
3.4.3.1 U.S. Orthopedic Imaging Modalities Market (by Application)
3.5 Magnetic Resonance Imaging (MRI) Systems
3.5.1 Market Dynamics
3.5.2 Procedure Volume
3.5.2.1 U.S. Orthopedic Imaging Modalities Market (by Application)
3.5.2.2 U.S. Orthopedic Imaging Modalities Market (by State)
3.5.3 Market Size and Forecast
3.5.3.1 U.S. Orthopedic Imaging Modalities Market (by Application)
3.6 Ultrasound Systems
3.6.1 Market Dynamics
3.6.2 Procedure Volume
3.6.2.1 U.S. Orthopedic Imaging Modalities Market (by Application)
3.6.2.2 U.S. Orthopedic Imaging Modalities Market (by State)
3.6.3 Market Size and Forecast
3.6.3.1 U.S. Orthopedic Imaging Modalities Market (by Application)
4 U.S. Orthopedic Imaging Modalities Market (by End User)
4.1 Overview
4.2 Growth-Share Matrix
4.3 Hospitals
4.4 Ambulatory Surgical Centers
4.5 Others
5 U.S. Orthopedic Surgical Navigation Systems Market (by Application)
5.1 Overview
5.2 Growth-Share Matrix
5.3 Joints
5.4 Spine
6 Market – Competitive Benchmarking & Company Profiles
6.1 Competitive Benchmarking
6.1.1 Competitive Landscape
6.1.1.1 Key Strategies and Developments
6.1.1.2 Regulatory and Legal Activities
6.1.1.3 New Offerings
6.1.1.4 Mergers and Acquisitions
6.1.1.5 Partnerships, Collaborations, and Business Expansion Activities
6.1.2 Key Development Analysis
6.2 Company Profiles
6.2.1 Canon Inc.
6.2.1.1 Company Overview
6.2.1.2 Role of Canon Inc. in the U.S. Orthopedics Imaging Modalities and Surgical Navigation Systems Market
6.2.1.3 Product Portfolio
6.2.1.4 Financials
6.2.1.5 Recent Developments
6.2.1.6 Analyst Perception
6.2.2 FUJIFILM Holdings Corporation
6.2.2.1 Company Overview
6.2.2.2 Role of FUJIFILM Holdings Corporation in the U.S. Orthopedics Imaging Modalities and Surgical Navigation Systems Market
6.2.2.3 Product Portfolio
6.2.2.4 Financials
6.2.2.5 Recent Developments
6.2.2.6 Analyst Perception
6.2.3 General Electric Company
6.2.3.1 Company Overview
6.2.3.2 Role of General Electric Company in the U.S. Orthopedic Imaging Modalities and Surgical Navigation Systems Market
6.2.3.3 Product Portfolio
6.2.3.4 Financials
6.2.3.5 Recent Developments
6.2.3.6 Analyst Perception
6.2.4 Johnson & Johnson
6.2.4.1 Company Overview
6.2.4.2 Role of Johnson & Johnson in the U.S. Orthopedic Imaging Modalities and Surgical Navigation Systems Market
6.2.4.3 Product Portfolio
6.2.4.4 Financials
6.2.4.5 Recent Developments
6.2.4.6 Analyst Perception
6.2.5 Konica Minolta, Inc.
6.2.5.1 Company Overview
6.2.5.2 Role of Konica Minolta Inc. in the U.S. Orthopedic Imaging Modalities and Surgical Navigation Systems Market
6.2.5.3 Product Portfolio
6.2.5.4 Financials
6.2.5.5 Analyst Perspectives
6.2.6 Koninklijke Philips N.V.
6.2.6.1 Company Overview
6.2.6.2 Role of Koninklijke Philips N.V. in the U.S. Orthopedic Imaging Modalities and Surgical Navigation Systems Market
6.2.6.3 Product Portfolio
6.2.6.4 Financials
6.2.6.5 Recent Developments
6.2.6.6 Analyst Perception
6.2.7 Medtronic plc
6.2.7.1 Company Overview
6.2.7.2 Role of Medtronic plc in the U.S. Orthopedic Imaging Modalities and Surgical Navigation Systems Market
6.2.7.3 Product Portfolio
6.2.7.4 Financials
6.2.7.5 Recent Developments
6.2.7.6 Analyst Perception
6.2.8 OrthAlign, Inc.
6.2.8.1 Company Overview
6.2.8.2 Role of OrthAlign, Inc. in the U.S. Orthopedic Imaging Modalities and Surgical Navigation Systems Market
6.2.8.3 Product Portfolio
6.2.8.4 Recent Developments
6.2.8.5 Analyst Perception
6.2.9 Shimadzu Corporation
6.2.9.1 Company Overview
6.2.9.2 Role of Shimadzu Corporation in the U.S. Orthopedic Imaging Modalities and Surgical Navigation Systems Market
6.2.9.3 Product Portfolio
6.2.9.4 Financials
6.2.9.5 Recent Developments
6.2.9.6 Analyst Perception
6.2.10 Siemens Healthineers AG
6.2.10.1 Company Overview
6.2.10.2 Role of Siemens Healthineers AG in the U.S. Orthopedic Imaging Modalities and Surgical Navigation Systems Market
6.2.10.3 Product Portfolio
6.2.10.4 Financials
6.2.10.5 Recent Developments
6.2.10.6 Analyst Perspectives
6.2.11 Smith & Nephew plc
6.2.11.1 Company Overview
6.2.11.2 Role of Smith & Nephew plc in the U.S. Orthopedic Imaging Modalities and Surgical Navigation Systems Market
6.2.11.3 Product Portfolio
6.2.11.4 Financials
6.2.11.5 Analyst Perception
6.2.12 SonoScape Medical Corp.
6.2.12.1 Company Overview
6.2.12.2 Role of SonoScape Medical Corp. in the U.S. Orthopedic Imaging Modalities and Surgical Navigation Systems Market
6.2.12.3 Product Portfolio
6.2.12.4 Analyst Perception
6.2.13 Stryker Corporation
6.2.13.1 Company Overview
6.2.13.2 Role of Stryker Corporation in the U.S. Orthopedic Imaging Modalities and Surgical Navigation Systems Market
6.2.13.3 Product Portfolio
6.2.13.4 Financials
6.2.13.5 Analyst Perception
6.2.14 United Imaging Healthcare Co., Ltd.
6.2.14.1 Company Overview
6.2.14.2 Role of United Imaging Healthcare Co., Ltd. in the U.S. Orthopedic Imaging Modalities and Surgical Navigation Systems Market
6.2.14.3 Product Portfolio
6.2.14.4 Recent Developments
6.2.14.5 Analyst Perception
6.2.15 Zimmer Biomet Holdings, Inc.
6.2.15.1 Company Overview
6.2.15.2 Role of Zimmer Biomet Holdings, Inc. in the U.S. Orthopedic Imaging Modalities and Surgical Navigation Systems Market
6.2.15.3 Product Portfolio
6.2.15.4 Financials
6.2.15.5 Recent Developments
6.2.15.6 Analyst Perception
List of Figures
Figure 1: U.S. Orthopedic Imaging Modalities Market, $Million, 2020-2031
Figure 2: U.S. Orthopedic Imaging Modalities Market Dynamics, Impact Analysis
Figure 3: U.S. Orthopedic Surgical Navigation Systems Market, $Million, 2020-2031
Figure 4: U.S. Orthopedic Surgical Navigation Systems Market Dynamics, Impact Analysis
Figure 5: Segmentation of U.S. Orthopedic Imaging Modalities Market, $Million, 2020-2031
Figure 6: Segmentation of U.S. Orthopedic Surgical Navigation Systems Market, $Million, 2020-2031
Figure 7: U.S. Orthopedic Imaging Modalities and Surgical Navigation Systems Market, Research Methodology
Figure 8: Primary Research
Figure 9: Secondary Research
Figure 10: Data Triangulation
Figure 11: U.S. Orthopedic Imaging Modalities and Surgical Navigation Systems Market, Research Process
Figure 12: Assumptions and Limitations
Figure 13: U.S. Orthopedic Imaging Modalities Market, Potential Forecast Scenarios
Figure 14: U.S. Orthopedic Imaging Modalities Market Size and Growth Potential (Realistic Scenario), $Million, 2020-2031
Figure 15: U.S. Orthopedic Imaging Modalities Market Size and Growth Potential (Optimistic Scenario), $Million, 2020-2031
Figure 16: U.S. Orthopedic Imaging Modalities Market Size and Growth Potential (Pessimistic Scenario), $Million, 2020-2031
Figure 17: U.S. Orthopedic Surgical Navigation Systems Market, Potential Forecast Scenarios
Figure 18: U.S. Orthopedic Surgical Navigation Systems Market Size and Growth Potential (Realistic Scenario), $Million, 2020-2031
Figure 19: U.S. Orthopedic Surgical Navigation Systems Market Size and Growth Potential (Optimistic Scenario), $Million, 2020-2031
Figure 20: U.S. Orthopedic Surgical Navigation Systems Market Size and Growth Potential (Pessimistic Scenario), $Million, 2020-2031
Figure 21: U.S. Orthopedic Imaging Modalities Market, Patent Analysis (by Year), January 2018-September 2022
Figure 22: U.S. Orthopedic Surgical Navigation Systems Market, Patent Analysis (by Year), January 2018-September 2022
Figure 23: U.S. Orthopedic Imaging Modalities and Surgical Navigation Systems Market, Orthopedic Imaging Modalities (by Modality), Product Benchmarking
Figure 24: U.S. Orthopedic Imaging Modalities Market, Impact Analysis
Figure 25: Recent Advances in Imaging and Radiology in Orthopedics
Figure 26: U.S. Orthopedic Imaging Modalities Market, Business Trends
Figure 27: U.S. Orthopedic Surgical Navigation Systems Market, Impact Analysis
Figure 28: Total Knee Arthroplasty, Procedure Volume, Unit, 2020-2040
Figure 29: Total Hip Arthroplasty, Procedure Volume, Unit, 2020-2040
Figure 30: Post-Operative Complications, Minimally Invasive Surgeries (MIS) vs. Open Procedure, 2019
Figure 31: U.S. Orthopedic Imaging Modalities Market (by Application)
Figure 32: U.S. Orthopedic Imaging Modalities Market, Incremental Opportunity (by Application), 2021-2031
Figure 33: U.S. Orthopedic Imaging Modalities Market, Growth-Share Matrix (by Application), 2021-2031
Figure 34: U.S. Orthopedic Imaging Modalities Market (Hip), $Million, 2020-2031
Figure 35: U.S. Orthopedic Imaging Modalities Market (Knee), $Million, 2020-2031
Figure 36: U.S. Orthopedic Imaging Modalities Market (Spine), $Million, 2020-2031
Figure 37: U.S. Orthopedic Imaging Modalities Market (Other Extremities), $Million, 2020-2031
Figure 38: U.S. Orthopedic Imaging Modalities Market (by Modality)
Figure 39: U.S. Orthopedic Imaging Modalities Market, Incremental Opportunity (by Modality), 2021-2031
Figure 40: U.S. Orthopedic Imaging Modalities Market, Growth-Share Matrix (by Modality), 2021-2031
Figure 41: U.S. Orthopedic Imaging Modalities Market (X-Ray), Market Dynamics
Figure 42: Key Trends in X-Ray
Figure 43: U.S. Orthopedic Imaging Modalities Market (X-Ray), Procedure Volume, 2020-2031
Figure 44: U.S. Orthopedic Imaging Modalities Market, X-Ray (by Application), Procedure Volume, 2020-2031
Figure 45: U.S. Orthopedic Imaging Modalities Market X-Ray (by State), Procedure Volume, 2021
Figure 46: U.S. Orthopedic Imaging Modalities Market (X-Ray), $Million, 2020-2031
Figure 47: U.S. Orthopedic Imaging Modalities Market, X-Ray (by Application), $Million, 2020-2031
Figure 48: U.S. Orthopedic Imaging Modalities Market, Computed Tomography (CT) Scanners, Market Dynamics
Figure 49: Key Trends in Computed Tomography (CT) Scanners
Figure 50: U.S. Orthopedic Imaging Modalities Market (Computed Tomography (CT) Scanners), Procedure Volume, 2020-2031
Figure 51: U.S. Orthopedic Imaging Modalities Market, Computed Tomography Scanners (by Application), Procedure Volume, 2020-2031
Figure 52: U.S. Orthopedic Imaging Modalities Market, Computed Tomography (CT) Scanner (by State), Procedure Volume, 2021
Figure 53: U.S. Orthopedic Imaging Modalities Market (Computed Tomography (CT) Scanners), $Million, 2020-2031
Figure 54: U.S. Orthopedic Imaging Modalities Market, Computed Tomography (CT) Scanners (by Application), $Million, 2020-2031
Figure 55: Types of Magnetic Resonance Imaging (MRI) Systems
Figure 56: U.S. Orthopedic Imaging Modalities Market (Magnetic Resonance Imaging (MRI) Systems), Market Dynamics
Figure 57: U.S. Orthopedic Imaging Modalities Market (Magnetic Resonance Imaging (MRI ) Systems), Market Trends
Figure 58: U.S. Orthopedic Imaging Modalities Market (Magnetic Resonance Imaging (MRI) Systems), Procedure Volume, 2020-2031
Figure 59: U.S. Orthopedic Imaging Modalities Market, MRI Systems (by Application), Procedure Volume, 2020-2031
Figure 60: U.S. Orthopedic Imaging Modalities Market, Magnetic Resonance Imaging (MRI) Systems (by State), Procedure Volume, 2021
Figure 61: U.S. Orthopedic Imaging Modalities Market (Magnetic Resonance Imaging (MRI) Systems), $Million, 2020-2031
Figure 62: U.S. Orthopedic Imaging Modalities Market, Magnetic Resonance Imaging (MRI) Systems (by Application), $Million, 2020-2031
Figure 63: U.S. Orthopedic Imaging Modalities Market (Ultrasound Systems), Market Dynamics
Figure 64: U.S. Orthopedic Imaging Modalities Market (Ultrasound Systems), Procedure Volume, 2020-2031
Figure 65: U.S. Orthopedic Imaging Modalities Market, Ultrasound Systems (by Application), Procedure Volume, 2020-2031
Figure 66: U.S. Orthopedic Imaging Modalities Market, Ultrasound Systems (by State), Procedure Volume, 2021
Figure 67: U.S. Orthopedic Imaging Modalities Market (Ultrasound Systems), $Million, 2020-2031
Figure 68: U.S. Orthopedic Imaging Modalities Market, Ultrasound Systems (by Application), $Million, 2020-2031
Figure 69: U.S. Orthopedic Imaging Modalities Market (by End User)
Figure 70: U.S. Orthopedic Imaging Modalities Market, Incremental Opportunity (by End User), 2021-2031
Figure 71: U.S. Orthopedic Imaging Modalities Market, Growth-Share Matrix (by End User), 2021-2031
Figure 72: U.S. Orthopedic Imaging Modalities Market (Hospitals), $Million, 2020-2031
Figure 73: U.S. Orthopedic Imaging Modalities Market (Ambulatory Surgery Centers), $Million, 2020-2031
Figure 74: U.S. Orthopedic Imaging Modalities Market (Others), $Million, 2020-2031
Figure 75: U.S. Orthopedic Surgical Navigation Systems Market (by Application)
Figure 76: U.S. Orthopedic Surgical Navigation Systems Market, Incremental Opportunity (by Application), 2021-2031
Figure 77: U.S. Orthopedic Surgical Navigation Systems Market, Growth-Share Matrix (by Application), 2021-2031
Figure 78: U.S. Orthopedic Surgical Navigation Systems Market (Joints), $Million, 2020-2031
Figure 79: U.S. Orthopedic Surgical Navigation Systems Market (Joints), $Million, 2020-2031
Figure 80: U.S. Orthopedic Surgical Navigation Systems Market (Spine), $Million, 2020-2022
Figure 81: U.S. Orthopedic Imaging Modalities and Surgical Navigation Systems Market, Total Number of Key Developments, January 2012-September 2022
Figure 82: Regulatory and Legal Activities, January 2019- September 2022
Figure 83: New Offerings, January 2019-September 2022
Figure 84: Mergers and Acquisitions, January 2019-September 2022
Figure 85: Partnerships, Alliances, and Business Expansion Activities, January 2019-September 2022
Figure 86: U.S. Orthopedic Imaging Modalities and Surgical Navigation Systems Market, Key Development Analysis, January 2012-September 2022
Figure 87: Canon Inc.: Some of the Product Portfolio
Figure 88: Canon, Inc.: Overall Financials, $Million, 2019-2021
Figure 89: Canon, Inc.: Net Revenue (by Segment), $Million, 2019-2021
Figure 90: Canon, Inc.: Revenue (by Region), 2019-2021
Figure 91: Canon, Inc.: R&D Expenditure, $Million, 2019-2021
Figure 92: FUJIFILM Holdings Corporation: Some of the Product Portfolio
Figure 93: FUJIFILM Holdings Corporation: Overall Financials, $Million, 2019-2021
Figure 94: FUJIFILM Holdings Corporation: Net Revenue (by Segment), $Million, 2020-2021
Figure 95: FUJIFILM Holdings Corporation: Net Revenue (by Region), $Million, 2018-2020
Figure 96: FUJIFILM Holdings Corporation: R&D Expenditure, $Million, 2018-2020
Figure 97: General Electric Company: Some of the Product Portfolio
Figure 98: General Electric Company.: Overall Financials, $Million, 2019-2021
Figure 99: General Electric Company: Net Revenue (by Segment), $Million, 2019-2021
Figure 100: General Electric Company: Net Revenue (by Region), $Million, 2019-2021
Figure 101: General Electric Company: R&D Expenditure, $Million, 2019-2021
Figure 102: Johnson & Johnson: Overall Product Portfolio
Figure 103: Johnson & Johnson: Overall Financials, $Million, 2019-2021
Figure 104: Johnson & Johnson: Revenue (by Segment), $Million, 2019-2021
Figure 105: Johnson & Johnson: Revenue (by Region), $Million 2019-2021
Figure 106: Johnson & Johnson: R&D Expenditure, $Million, 2019-2021
Figure 107: Konica Minolta, Inc.: Overall Product Portfolio
Figure 108: Konica Minolta, Inc.: Overall Financials 2019-2021
Figure 109: Konica Minolta, Inc.: Net Revenue (by Segment), $Million, 2019-2021
Figure 110: Konica Minolta, Inc.: Net Revenue (by Region), $Million, 2019-2021
Figure 111: Konica Minolta, Inc.: R&D Expenditure, $Million, 2019-2021
Figure 112: Koninklijke Philips N.V.: Some of the Product Portfolio
Figure 113: Koninklijke Philips N.V.: Overall Financials, $Million, 2019-2021
Figure 114: Koninklijke Philips N.V.: Revenue (by Segment), $Million, 2019-2021
Figure 115: Koninklijke Philips N.V.: Revenue (by Region), $Million, 2019-2021
Figure 116: Koninklijke Philips N.V.: R&D Expenditure, $Million, 2019-2021
Figure 117: Medtronic plc: Overall Product Portfolio
Figure 118: Medtronic plc: Overall Financials, $Million, 2020-2022
Figure 119: Medtronic plc: Revenue (by Segment), $Million, 2020-2022
Figure 120: Medtronic plc: Revenue (by Region), $Million 2020-2022
Figure 121: Medtronic plc: R&D Expenditure, $Million, 2020-2022
Figure 122: OrthAlign, Inc.: Some of the Product Portfolio
Figure 123: Shimadzu Corporation: Some of the Product Portfolio
Figure 124: Shimadzu Corporation: Overall Financials, $Million, 2019-2021
Figure 125: Shimadzu Corporation: Net Revenue (by Segment), $Million, 2019-2021
Figure 126: Shimadzu Corporation: R&D Expenditure, $Million, 2019-2021
Figure 127: Siemens Healthineers AG: Some of the Product Portfolio
Figure 128: Siemens Healthineers AG: Overall Financials, $Million, 2019-2021
Figure 129: Siemens Healthineers AG: Net Revenue (by Segment), $Million, 2019-2021
Figure 130: Siemens Healthineers AG: Net Revenue (by Region), $Million, 2019-2021
Figure 131: Siemens Healthineers AG: R&D Expenditure, $Million, 2019-2021
Figure 132: Smith & Nephew plc: Overall Product Portfolio
Figure 133: Smith & Nephew plc: Overall Financials, $Million, 2019-2021
Figure 134: Smith & Nephew plc: Revenue (by Segment), $Million, 2019-2021
Figure 135: Smith & Nephew plc: Revenue (by Region), $Million 2019-2021
Figure 136: Smith & Nephew plc: R&D Expenditure, $Million, 2019-2021
Figure 137: SonoScape Medical Corp.: Overall Product Portfolio
Figure 138: Stryker Corporation: Overall Product Portfolio
Figure 139: Stryker Corporation: Overall Financials, $Million, 2019-2021
Figure 140: Stryker Corporation: Revenue (by Segment), $Million, 2019-2021
Figure 141: Stryker Corporation: Sub-Segment Revenues (MedSurg and Neurotechnology), $Million 2019-2021
Figure 142: Stryker Corporation: Revenue (by Region), $Million 2019-2021
Figure 143: Stryker Corporation: R&D Expenditure, $Million, 2019-2021
Figure 144: United Imaging Healthcare Co., Ltd.: Overall Product Portfolio
Figure 145: Zimmer Biomet Holdings, Inc.: Product Portfolio
Figure 146: Zimmer Biomet Holdings, Inc.: Overall Financials, $Million, 2019-2021
Figure 147: Zimmer Biomet Holdings, Inc.: Revenue (by Segment), $Million, 2020-2021
Figure 148: Zimmer Biomet Holdings, Inc.: Revenue (by Region), $Million, 2019-2021
Figure 149: Zimmer Biomet Holdings, Inc.: R&D Expenditure, $Million, 2019-2021
List of Tables
Table 1: Key Questions Answered in this Report
Table 2: Parameters for Realistic, Optimistic, and Realistic Growth Scenarios
Table 3: Parameters for Realistic, Optimistic, and Realistic Growth Scenarios
Table 4: U.S. Orthopedic Imaging Modalities Market, Awaited Technologies
Table 5: U.S. Orthopedic Surgical Navigation Systems Market, Awaited Technologies
Table 6: Types of X-Rays (by Modality)
Table 7: Types of Ultrasound Systems (by Technology)
Table 8: Canon Inc.: Key Products and Features
Table 9: FUJIFILM Holdings Corporation: Key Products and Features
Table 10: General Electric Company: Key Products and Features
Table 11: Johnson & Johnson: Key Products and Features
Table 12: Konica Minolta, Inc.: Key Products and Features
Table 13: Koninklijke Philips N.V.: Key Products and Features
Table 14: Medtronic plc: Key Products and Features
Table 15: OrthAlign, Inc.: Key Products and Features
Table 16: Shimadzu Corporation: Key Products and Features
Table 17: Siemens Healthineers AG: Key Products and Features
Table 18: Smith & Nephew plc: Key Products and Features
Table 19: SonoScape Medical Corp.: Key Products and Features
Table 20: Stryker Corporation: Key Products and Features
Table 21: United Imaging Healthcare Co., Ltd.: Key Products and Features
Table 22: Zimmer Biomet Holdings, Inc.: Key Products and Features

The post U.S. Orthopedic Imaging Modalities and Orthopedic Surgical Navigation Systems Market: Focus on Modality, Application, and End User – Analysis and Forecast, 2022-2031 first appeared on CRI Report.

The global agriculture autonomous robots market was valued at $3.92 billion in 2021 and is projected to reach $10.50 billion in 2027, growing at a CAGR of 19.16% during the forecast period 2022-2027. The growth in the global agriculture autonomous robots market is expected to be driven by increasing demand for food and the growing need for precision, digital, and smart agriculture practices.

Market Lifecycle Stage

The agriculture autonomous robots market is still in an evolving phase. Increased research and development activities are underway to develop agriculture autonomous robotic technologies and products, which are expected to increase due to the increased demand for food and the need for automation in the agriculture sector.

Increasing investment in smart agriculture is one of the major opportunities in the global agriculture autonomous robots market. Moreover, agriculture autonomous robot technologies also help in reducing crop losses due to undetected pest infestation and diseases. The agriculture autonomous robots also facilitate the safe and quality harvesting and picking of crops including fruits and vegetables.

Impact

• With an increased worldwide focus on achieving the global food demand, the shift to digital, smart, and data-driven products in the agriculture sectors brings significant sales and financing opportunities. The shift is more prominent in automation and robotics segments in regions such as North America and Europe.
• Furthermore, agriculture autonomous robots have a moderate to high impact on crop protection systems to reduce crop losses due to crop diseases and pest infestations.

Impact of COVID-19

In the wake of the pandemic, labor shortages have caused disruptions in the agricultural processes, thereby leading every country to re-emphasize food security and increase domestic food production. With an aim to solve labor shortages, the increased application of automated technologies such as sensors, data analytics, robotics, and others have been introduced into the production system. Each country continued to promote policies on increasing the adoption of agriculture autonomous robots techniques, which have proved to be the appropriate solution.

Market Segmentation:

Segmentation 1: by Application
• Crop Monitoring
• Inventory Management
• Harvesting and Picking
• Dairy Farm Management
• Others

Dairy farm management is one of the major applications of agriculture autonomous robots owing to the high adoption of milking robots in Europe and North America.

Segmentation 2: by Product
• Weeding Robots
• Crop Harvesting Robots
• Milking Robots
• Others

The milking robots segment is expected to grow at a CAGR of 20.34% during the forecast period 2022-2027 due to the rising use of automation in dairy farms. These robots increase the efficiency of farm operations by reducing the overall cost. Hence, farmers are inclining toward adopting milking robots and reducing dependence on manual labor.

Segmentation 3: by Region
• North America – U.S., Canada, and Mexico
• Europe – Italy, Germany, France, and Rest-of-Europe
• China
• U.K.
• Asia-Pacific- Japan, India, South Korea, and Rest-of-Asia-Pacific
• Rest-of-the-World – South America, Middle East and Africa

North America generated the highest revenue of $1.33 billion in 2021, which is attributed to the R&D advancements and supporting government regulations in the region. Europe is an attractive region for the agriculture autonomous robots market because of the availability of the different market fragments.

Recent Developments in Global Agriculture Autonomous Robots Market

• In April 2022, Verdant Robotics announced a robotic solution for farms that can help in spraying and weeding simultaneously with the help of machine learning, AI perception, and robotics technology.
• In December 2021, Lely collaborated with Dutch based Connectera B.V. With this collaboration, Lely aims to use Connecterra B.V.’s advancements in machine learning and artificial intelligence to provide more insights to farmers. Also, the technologies aid in integrating farm technologies with artificial intelligence for developing farm management systems.
• In October 2021, BouMatic acquired SAC Group, a well-reputed full-line producer of complete milking systems for cows, sheep, and goats. This acquisition is expected to aid BouMatic in expanding its global presence and product catalogue.
• In November 2020, Robert Bosch GmbH and BASF SE began a joint venture for digital technologies in the agricultural sector. They jointly developed a smart spraying technology to apply herbicide on weeds without spraying unaffected areas of crops.
• In October 2020, AGCO Corporation announced the launch of Fendt Xaver, which comes with an embedded solution developed by the AGCO Group and a seed unit for precision planting. It is equipped with the Vario Guide Lane guidance system, which controls the robot with centimetre accuracy.

Demand – Drivers and Limitations

Following are the demand drivers for the agriculture autonomous robots market:

• Growing Focus on Environmental Sustainability
• Aging Workforce Leading to Skill Shortage
• Escalating Adoption of Precision Agriculture Technologies

The market is expected to face some limitations too due to the following challenges:

• High Initial Investment and Cost
• Less Adoption among Small-Scale Farmers

How can this report add value to an organization?

Product/Innovation Strategy: The product segment helps the reader understand the different types of agriculture autonomous robots technologies available for deployment in the agriculture sector and their potential globally. Moreover, the study provides the reader with a detailed understanding of the different agriculture autonomous robots by application and by product.

Growth/Marketing Strategy: The global agriculture autonomous robots market has seen major development by key players operating in the market, such as business expansion, partnership, collaboration, and joint venture. The favored strategy for the companies has been product partnerships, joint ventures, and product launches to strengthen their position in the agriculture autonomous robots market. For instance, in November 2020, Robert Bosch GmbH and BASF SE began a joint venture for digital technologies in the agricultural sector. They jointly developed a smart spraying technology to apply herbicide on weeds without spraying unaffected areas of crops.

Competitive Strategy: Key players in the global agriculture autonomous robots market analyzed and profiled in the study involve agriculture autonomous robots manufacturers that provide different products. Moreover, a detailed competitive benchmarking of the players operating in the global agriculture autonomous robots market has been done to help the reader understand how players stack against each other, presenting a clear market landscape. Additionally, comprehensive competitive strategies such as partnerships, agreements, and collaborations will aid the reader in understanding the untapped revenue pockets in the market.

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, product portfolio, and market penetration.

The top segment players leading the market include crop monitoring and dairy farm management, which capture around 65% of the presence in the market. Players in other technologies, such as inventory management, and harvesting and picking, account for approximately 35% of the presence in the market, as of 2021.

Some of the prominent names established in this market are:

• AGCO Corporation
• Agrobot
• BouMatic
• DAIRYMASTER
• Deere & Company
• Ecorobotix SA
• GEA Group Aktiengesellschaft
• KUBOTA Corporation
• Lely
• Naio Technologies
• Robert Bosch GmbH
• Saga Robotics AS
• Uniseed
• Verdant Robotics

The post Agriculture Autonomous Robots Market – A Global and Regional Analysis: Focus Product and Application, Supply Chain Analysis, and Country Analysis – Analysis and Forecast, 2022-2027 first appeared on CRI Report.

Market Overview
Global Solar Control Window Films Market is anticipated to register significant growth at a CAGR of around 9.3% to surpass USD 6.2 Billion by the forecast period of 2027. The solar control window film is used to regulate sun radiations and heat. These films are usually put up on the inner side of windows to avoid UV radiation, heat gain, and excess sunlight and glare. Solar control window films are avoiding the steady heat build-up from occurring owing to the sunlight streaming through the glass, resulting in a more stable and moderate temperature.
The global solar control windows marker is expected to register notable market growth owing to the increasing demand for solar control window films in residential and commercial buildings and the growing automotive industry in emerging economies. The building & construction and automotive industries are the major customers of solar control windows in the market. Additionally, the widespread use of solar control films in the automotive industry is the other prime factor fuelling the market growth. However, the alternative solar control techniques and products are anticipated to hinder the market growth during the review period. Furthermore, the expected growth of the automotive market in the emerging economies of Asia-Pacific, Latin America, and the Middle East & Africa and the widespread use of solar control films in automobiles, the requirement for solar control window films is anticipated to register healthy growth in future.
Market Segmentation
Global Solar Control Window Films Market has been classified into Type, Absorber Type, and Application.
In terms of type, the global solar control window films market has been divided into dyed, vacuum, clear, and others.
By absorber type, the global market has been categorized into organic, inorganic, and metallic.
Based on application, the global market has been classified into construction, automotive and transportation, marine, decorative, and others.
Regional Analysis
Geographically, the global Solar Control Window Films Market has been segmented into five major regions namely North America, Asia-Pacific, Europe, Latin America, and the Middle East & Africa.
The market in the North American region is expected to register as the largest market owing to the largest market share of 34.4% in 2019. The regional market growth is driven by the increasing infrastructural development 5
in North America.
Asia-Pacific is expected to exhibit the rapidly developing market to witness a notable CAGR of 10.9% during the review period. The regional market growth is propelled by the expanding industrialization and commercialization in emerging economies such as India, Thailand, and South Korea. Additionally, the growing requirement for commercial space owing to the growth of service sectors such as information technology, banking, financial services, and insurance, and telecommunications is fuelling the growth of solar-controlled window films in the region during the review period.
Major Players
The Prominent Players in the Global Solar Control Window Films Market are 3M (US), The Window Film Company (UK), Eastman Chemical Company (US), Garware Suncontrol (India), Avery Dennison Corporation (US), Saint-Gobain (France), Madico, Inc (US), Solar Screen International SA (Luxembourg), Johnson Laminating & Coating, Inc (US), and NEXFILUSA (US).
COVID 19 Impacts
We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries. Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.

The post Global Solar Control Window Films Market Research Report – Forecast till 2027 first appeared on CRI Report.